From Concerts to Cures: How Philanthropy Fuels a Bioelectronic Revolution

OLD WESTBURY, NY – July 29, 2026 – On a warm July evening, the lawns of Old Westbury Gardens played host to a performance by indie pop band AJR. But the music was secondary to the main event: raising money for medical research. The Feinstein Institutes for Medical Research, the scientific heart of Northwell Health, announced it had raised $3.5 million at its 21st annual Summer Concert. While impressive, the figure only hints at a much larger story. It represents the latest infusion of capital into an institution that is quietly pioneering a new frontier of medicine, translating philanthropic dollars into tangible, life-altering technology.

This single event, which has now cumulatively raised nearly $50 million, isn’t just a feel-good charity function; it’s a critical component of a strategic financial model powering breakthroughs that are moving from the laboratory to the operating room. It highlights a powerful symbiosis where community generosity directly fuels the engine of innovation, particularly in the nascent and revolutionary field of bioelectronic medicine.

The New Frontier: Bioelectronic Medicine Takes Center Stage

For decades, medicine has largely relied on a chemical arsenal—pills and injections—to combat disease. The Feinstein Institutes are at the forefront of a paradigm shift toward an electrical one. Bioelectronic medicine is an emerging field that uses technology to read and modulate the body’s electrical signals, particularly through the nervous system, to treat disease and injury. Instead of a drug, the treatment is a targeted electrical impulse.

This isn't science fiction; it's a clinical reality pioneered by Northwell's research arm. The scientific foundation was laid by Dr. Kevin J. Tracey, president and CEO of the Feinstein Institutes, whose work identified the “inflammatory reflex”—a neural circuit that regulates the body's immune response through the vagus nerve. This discovery suggested that stimulating this nerve could control inflammation, the culprit behind a host of chronic diseases.

That foundational science has now borne fruit. In July 2025, the U.S. Food and Drug Administration (FDA) approved the SetPoint System, a “jellybean-sized” implantable vagus nerve stimulator for treating rheumatoid arthritis. Just one month later, in a national first, a Northwell Health surgical team at North Shore University Hospital implanted the device in a patient. For individuals suffering from moderate-to-severe rheumatoid arthritis with little response to existing drugs, this device represents a new horizon of hope, offering a non-pharmaceutical alternative.

“The Feinstein Summer Concert is an extraordinary partnership between our scientists and a community believing in a shared mission to produce knowledge to cure disease,” said Dr. Tracey. “Together, we make and advance the discoveries that will alleviate suffering, and lead to a better world for generations to come.” The journey from a scientific hypothesis about a neural reflex to an FDA-approved implant for patients is a testament to the long-term vision and persistent funding that philanthropy enables.

Mapping the Body's Electrical Grid

The initial success with rheumatoid arthritis is just the beginning. The next wave of innovation focuses on precision. The vagus nerve is a complex information superhighway, and early stimulation methods can be imprecise. To refine the therapy, researchers need a better map. This is the work of Dr. Stavros Zanos and his team at the Institute of Bioelectronic Medicine.

In a monumental effort funded by a $6.7 million multi-year grant from the National Institutes of Health (NIH), Dr. Zanos’s team undertook the painstaking task of creating the world’s first comprehensive 3D anatomical map of the human vagus nerve. The project, which took three years and involved samples from 30 human donors, provides an unprecedented view into the nerve’s microscopic anatomy. This publicly released dataset is a game-changer, allowing scientists to understand which nerve fibers control which bodily functions.

As Dr. Zanos shared with supporters at the concert, this work is crucial for developing more precise and personalized therapies. By understanding how to selectively activate specific nerve fibers, his team is developing advanced stimulation techniques that could enhance therapeutic effects while minimizing side effects. This precision targeting could unlock treatments for a wide range of conditions beyond arthritis, including inflammatory bowel disease and heart failure. This sophisticated research, supported by major federal grants, often begins with seed funding from philanthropic efforts like the summer concert, which allow for the high-risk, high-reward investigations that lead to major grants.

The Economic Engine of Innovation

Beyond the headlines of medical breakthroughs, Northwell Health operates as a powerful economic engine for the region. As New York State’s largest private employer with over 105,000 staff members and its largest healthcare provider, the system’s influence extends far beyond its 28 hospitals and 1,000-plus outpatient facilities. Its commitment to research is a strategic investment in the region’s future as a biotechnology hub.

The Feinstein Institutes, with 50 research labs and thousands of ongoing clinical studies, attract world-class scientific talent and significant federal funding, as evidenced by the millions in NIH grants awarded to its researchers. This creates a virtuous cycle: philanthropic donations de-risk early-stage research, which then attracts major government and private investment, which in turn leads to commercial applications and improved patient care. This model solidifies New York’s position on the global stage for medical innovation.

“Philanthropy is essential to transforming the future of medicine,” said John D’Angelo, MD, president and CEO of Northwell Health. “The generosity of our supporters empowers our physicians and scientists to pursue innovative solutions and expand what’s possible in healthcare.” This support is a cornerstone of Northwell’s ambitious $1.4 billion “Outpacing the Impossible” fundraising campaign, which aims to accelerate research and elevate patient care across the system. The $3.5 million raised at the concert is a vital piece of this much larger strategic financial puzzle.

A Model for Community-Fueled Science

The annual gathering at Old Westbury Gardens, emceed for a tenth year by CBS News anchor Chris Wragge, serves as a powerful model for how a community and a health system can partner to drive progress. The consistent success of the event over two decades demonstrates a deep reservoir of trust and a shared belief in the Feinstein Institutes' mission. The funds raised are not siloed; they support the full spectrum of the institutes' work, spanning behavioral science, cancer, molecular medicine, and more.

This diversified research portfolio ensures that the impact of one night’s fundraising ripples across multiple disciplines, tackling a wide array of diseases that affect millions. By connecting donors directly with the scientists their contributions support, Northwell has created a powerful, transparent, and enduring partnership. This alliance between community, philanthropy, and science is not just funding the next discovery; it is actively building the future of medicine, one breakthrough at a time.